Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: A randomized trial

Bone Marrow Transplantation

Volumn 17, Issue 4, 1996, Pages 527-531

  Vannucchi, A M ^a   Bosi, A ^a   Ieri, A ^a   Guidi, S ^a   Saccardi, R ^a   Lombardini, L ^a   Linari, S ^a   Laszlo, D ^a   Longo, G ^a   Rossi Ferrini, P ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Autologous bone marrow transplantation; Erythropoiesis; Erythropoietin; G CSF

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT ERYTHROPOIETIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROPOIESIS; HODGKIN DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

ANEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; ERYTHROPOIESIS; ERYTHROPOIETIN; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA; PILOT PROJECTS; PLATELET COUNT; RETICULOCYTE COUNT; SAFETY; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 9244237597     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891-895.
2. Schriber JR, Negrin RS, Chao NJ et al. The efficacy of granulocyte colony-stimulating factor following autologous bone marrow transplantation for non-Hodgkin's lymphoma with monoclonal antibody purged bone marrow. Leukemia 1993; 7: 1491-1495.
3. Link H, Boogaerts MA, Fauser AA et al. A controlled trial of recombinant human erythropoietin after bone marrow transplantation. Blood 1994; 84: 3327-3335.
4. Locatelli F, Zecca M, Pedrazzoli P et al. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplant 1994; 13: 403-410.
5. Vannucchi AM, Bosi A, Grossi A et al. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients. Leukemia 1992; 6: 215-219.
6. Steegman JL, Lopez J, Otero JM et al. Erythropoietin treatment in allogeneic BMT accelerates erythroid reconstitution: Results of a prospective controlled randomized trial. Bone Marrow Transplant 1992; 10: 541-546.
7. Gallicchio VS, Hughes NK. Effect of G-CSF and M-CSF on the in vitro toxicity associated with zidovudine in normal human bone marrow haematopoietic progenitor stem cells. Antiviral Chem Chemother 1993; 4: 309-313.
8. Broxmeyer HE, Benninger L, Patel SR et al. Kinetic response of human marrow myeloid progenitor cells to in vivo treatment of patients with granulocyte colony-stimulating factor is different from the response to treatment with granulocytemacrophage colony-stimulating factor. Exp Hematol 1994; 22: 100-102.
9. Negrin RS, Stein R, Vardiman J et al. Treatment of the anemia of myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor in combination with erythropoietin. Blood 1993; 82: 737-743.
10. Miles SA, Mitsuyasu RT, Moreno J et al. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decrease hematologic toxicity from zidovudine. Blood 1991; 77: 2109-2117.
11. Miles SA, Mitsuyasu RT, Lee K et al. Recombinant human granulocyte colony-stimulating factor increases circulating burst forming unit-erythron and red blood cell production in patients with severe immunodeficiency virus infection. Blood 1990; 11: 2137-2142.
12. Atkinson K. Reconstitution of the haemopoietic and immune systems after marrow transplantation. Bone Marrow Transplant 1990; 5: 209-226.
13. Bosi A, Vannucchi AM, Grossi A et al. Serum erythropoietin levels in patients undergoing autologous bone marrow transplantation. Bone Marrow Transplant 1992; 7: 421-425.
14. Lazarus HM, Goodnough LT, Goldwasser E et al. Serum erythropoietin levels and blood component therapy after autologous bone marrow transplantation: implications for erythropoietin therapy in this setting. Bone Marrow Transplant 1992; 10: 71-75.
15. Ireland RM, Atkinson K, Concannon A et al. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Br J Haematol 1990; 76: 128-134.
16. Schapira L, Antin JH, Ransil BJ et al. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990; 76: 2354-2359.
17. Miller CB, Jones RJ, Zahurak ML et al. Impaired erythropoietin response to anemia after bone marrow transplantation. Blood 1992; 80: 2677-2682.
18. Bosi A, Vannucchi AM, Grossi A et al. Inadequate erythropoietin production in allogeneic bone marrow transplant patients. Haematologica 1991; 76: 280-284.
19. Vannucchi AM, Grossi A, Bosi A et al. Impaired erythropoietin production in mice treated with cyclosporine A. Blood 1991; 78: 1615-1618.
20. Vannucchi AM, Grossi A, Bosi A et al. Effects of cyclosporin A on erythropoietin production by the human Hep3B hepatoma cell line. Blood 1993; 82: 978-984.
21. Faquin WC, Schneider TJ, Goldberg MA. Effect of inflammatory cytokines on hypoxia-induced erythropoietin production. Blood 1992; 79: 1987-1994.
22. Vannucchi AM, Grossi A, Rafanelli D et al. Inhibition of erythropoietin production in vitro by human interferon gamma. Br J Haematol 1994; 87: 18-23.
23. Beguin Y, Oris R, Fillet G. Dynamics of erythropoietin recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplant 1993; 11: 285-292.
24. McNiece I, Andrews R, Stewart M et al. Action of interleukin-3, G-CSF and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF. Blood 1989; 74: 110-114.
25. Pierelli L, Menichella G, Scambia G et al. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells. Bone Marrow Transplant 1994; 14: 23-30.
26. Chao NJ, Schriber JR, Long GD et al. A randomized study of erythropoietin and granulocyte colony-stimulating factor (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Blood 1994; 83: 2823-2828.
27. Christensen RD, Koening JM, Viskochil DH, Rothstein GD. Down-modulation of neutrophil production by erythropoietin in human hematopoietic clones. Blood 1989; 74: 817-822.
28. Christensen RD, Liecht KW, Koenig JM et al. Administration of erythropoietin to newborn rats results in diminished neutrophil production. Blood 1991; 78: 1241-1246.
29. de Haan G, Engel C, Dontje B et al. Mutual inhibition of marine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces. Blood 1994; 84: 4157-4163.
30. Locatelli F, Zecca M, Beguin Y et al. Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation. Br J Haematol 1993; 84: 752-754.